Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
ID: 345794Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/345794

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-077.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a Collaborative Program Grant (RM1) to support multidisciplinary research teams focused on addressing complex biomedical questions aligned with the mission of the National Institute of General Medical Sciences (NIGMS). Each team, consisting of three to six Program Directors/Principal Investigators (PDs/PIs), must demonstrate a cohesive approach to achieve significant scientific advancements that cannot be accomplished through individual efforts. This funding opportunity emphasizes the importance of diversity in research, requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity in team composition and project goals. Funding is available for up to five years, with requests of up to $1.5 million in direct costs per year, and the NIH anticipates awarding 4 to 6 grants per fiscal year based on application quality and available funding. Interested applicants can find more information and application guidelines at the NIH website and should direct inquiries to grantsinfo@nih.gov. The application deadline is January 27, 2026.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-077-Full-Announcement.html
    PAR-23-077.html
    The National Institutes of Health (NIH) is offering a Collaborative Program Grant (RM1) to support multidisciplinary research teams aimed at addressing complex biomedical questions within the mission of the National Institute of General Medical Sciences (NIGMS). Each team, consisting of three to six Program Directors/Principal Investigators (PDs/PIs), must demonstrate a cohesive approach to achieve significant scientific advancements that individual projects could not. This funding opportunity emphasizes the importance of diversity in research, requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) to ensure inclusivity in team composition and project goals. Successful applications should propose innovative research programs, with funding available for up to five years, allowing for requests of up to $1.5 million in direct costs per year. The NIH anticipates providing 4 to 6 awards per fiscal year, contingent on the quality of applications and available funding. Interested institutions must adhere to rigorous application guidelines and maintain various registrations, ensuring compliance with all eligibility requirements. This initiative reflects NIH's commitment to fostering collaborative efforts in advancing biomedical research, particularly through diverse and integrated scientific approaches.
    Similar Opportunities
    NIDA Program Project Grant Applications (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is inviting applications for Program Project Grants (P01 Clinical Trial Optional) aimed at fostering collaborative, multidisciplinary research on substance use disorders. Applicants must propose a minimum of three interrelated research projects that demonstrate scientific and administrative synergy under a unifying theme, addressing critical issues such as neuroscience, genetics, behavior, prevention, treatment, and health services related to substance use. This funding opportunity emphasizes inclusivity, requiring a Plan for Enhancing Diverse Perspectives (PEDP) and encouraging participation from underrepresented groups, with a maximum project duration of five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by January 7, 2026.
    Collaborative Opportunities for Multiple-disciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "Collaborative Opportunities for Multiple-disciplinary, Bold, and Innovative Neuroscience (COMBINE)," aimed at fostering innovative research in neuroscience through collaborative team science. This initiative encourages applications from transdisciplinary teams of 3-6 principal investigators (PDs/PIs) to tackle complex research questions that can lead to significant advancements in the field, particularly in overcoming barriers and achieving paradigm shifts in neuroscience. The program is designed to support projects that integrate diverse expertise across basic, clinical, and translational neuroscience domains, with the goal of transforming knowledge and practice within a five-year timeframe. Interested applicants are encouraged to prepare for this opportunity, with an estimated synopsis posting date of February 4, 2026, and a closing date for applications expected on June 23, 2026. For further inquiries, potential applicants can contact the NINDS Team Science Group at NINDSteamscience@nih.gov or by phone at 240-328-3447.
    Research Program Award (R35 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Research Program Award (R35 Clinical Trial Optional) aimed at providing long-term support and flexibility for Program Directors (PDs) and Principal Investigators (PIs) in the field of neurological research. This grant, which does not require cost sharing or matching, is designed to alleviate the administrative burdens associated with managing multiple grant applications, allowing researchers to focus on their scientific endeavors and mentorship roles. The funding, with an award ceiling of $750,000 and a floor of $350,000, is intended to foster innovative research that aligns with the mission of the National Institute of Neurological Disorders and Stroke (NINDS). Interested applicants can reach out to Alisa Schaefer at nindsr35@ninds.nih.gov for further information, with the estimated synopsis posting date set for April 15, 2026, and a projected award date of March 1, 2027.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIH Director’s Transformative Research Awards (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to announce the NIH Director’s Transformative Research Awards, a federal grant opportunity aimed at supporting innovative and unconventional research projects. This program encourages individual scientists or collaborative teams to propose groundbreaking research that has the potential to redefine scientific paradigms or develop transformative technologies, without the need for preliminary data or detailed experimental plans. With an estimated total funding of $8 million and the expectation of awarding seven grants, interested applicants should prepare their proposals in advance, as applications will be solicited starting June 20, 2025, with a closing date of September 3, 2025. For further inquiries, potential applicants can contact Dr. Patricia Labosky at TransformativeAwards@mail.nih.gov or by phone at 301-594-4863.
    National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health, through the National Cancer Institute (NCI), invites applications for Program Project grants (P01) aimed at fostering collaborative, multidisciplinary cancer research for the years 2023, 2024, and 2025. Applicants must propose at least three interrelated research projects and an Administrative Core, all centered around a common theme within the expansive field of cancer research, which includes areas such as cancer biology, prevention, diagnosis, treatment, and control. This funding opportunity is crucial for advancing cancer research and enhancing the effectiveness of collaborative efforts, with applications due by May 7, 2026. Interested parties can find more information and application guidelines at the provided link, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)" aimed at fostering international research collaborations that align with its mission. This grant supports projects that include at least one international subproject and are relevant to the scientific interests of participating NIH Institutes, Centers, and Offices (ICOs). The initiative is crucial for advancing health sciences by leveraging unique resources and expertise available in other countries, which may not be accessible in the United States. Interested applicants can reach out to the NIH Office of Policy for Extramural Research Administration (OPERA) via email at OPERAleadership@mail.nih.gov for further information, with applications due by January 25, 2026, and an estimated award date set for September 1, 2026.
    Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)." This initiative aims to support new investigators from diverse and underrepresented backgrounds in biomedical research, enabling them to conduct small-scale projects that align with the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other participating institutes. The grants, with a maximum budget of $125,000 per year for a project period not exceeding three years, are intended to facilitate the transition of these researchers toward independence while addressing health disparities. Interested applicants must demonstrate that they have had less than $125,000 in direct costs from combined active research funding and can submit proposals starting in early 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-097.html.
    Funding Opportunity for NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Director’s Pioneer Award Program, aimed at supporting innovative research projects with significant potential impact in health-related fields. This grant is designed for individual scientists of exceptional creativity who propose bold and high-risk research initiatives, emphasizing the investigator's qualities and the innovativeness of their proposals. The program anticipates awarding approximately $8.1 million across seven grants, with applications expected to open in June 2025 and close in September 2025. Interested applicants can reach out to Dr. Patricia Labosky at PioneerAwards@mail.nih.gov or by phone at 301-594-4863 for further information.
    Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Bioengineering Research Grants (BRG) under the R01 Clinical Trial Optional program, aimed at fostering collaborations between life and physical sciences to address biomedical challenges. The grants encourage multidisciplinary bioengineering approaches that integrate and accelerate the adoption of innovative tools and methods for research or clinical problems in basic, translational, or clinical science. This funding opportunity is particularly significant for small teams looking to enhance understanding and solve issues in biological and clinical sciences. Interested applicants can reach out to Dr. Miguel R. Ossandon at ossandom@mail.nih.gov or by phone at 240-276-5714, with an estimated award date of December 1, 2026, and a closing date for applications on February 5, 2026. The program anticipates awarding approximately 50 grants, with no cost-sharing or matching requirements.